{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T10:26:21Z","timestamp":1790331981993,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jceh.2018.07.005","type":"journal-article","created":{"date-parts":[[2018,7,17]],"date-time":"2018-07-17T15:26:41Z","timestamp":1531841201000},"page":"294-301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Expression Analysis of MicroRNA-21 and MicroRNA-122 in Hepatocellular Carcinoma"],"prefix":"10.1016","volume":"9","author":[{"given":"Dipu","family":"Bharali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basu D.","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mausumi","family":"Bharadwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed A.","family":"Husain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6775-0776","authenticated-orcid":false,"given":"Premashis","family":"Kar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jceh.2018.07.005_bib1","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/1753-6405.12108","article-title":"Incidence and management of hepatocellular carcinoma among M\u0101ori and non-M\u0101ori New Zealanders","volume":"37","author":"Chamberlain","year":"2013","journal-title":"Aust N Z J Public Health"},{"key":"10.1016\/j.jceh.2018.07.005_bib2","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.0510565103","article-title":"A\u00a0microRNA expression signature of human solid tumors defines cancer gene targets","volume":"103","author":"Volinia","year":"2006","journal-title":"J\u00a0Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jceh.2018.07.005_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-94-007-5590-1_1","article-title":"microRNAs in human cancer","volume":"774","author":"Farazi","year":"2013","journal-title":"J\u00a0Adv Exp Med Biol"},{"key":"10.1016\/j.jceh.2018.07.005_bib4","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrg2843","article-title":"The wide-spread regulation of microRNA biogenesis, function and decay","volume":"11","author":"Krol","year":"2010","journal-title":"J\u00a0Nat Rev Genet"},{"issue":"8","key":"10.1016\/j.jceh.2018.07.005_bib5","first-page":"1284","article-title":"DNA methylation regulates MicroRNA expression","volume":"6","author":"Han","year":"2007","journal-title":"J\u00a0Cancer Biol Ther"},{"key":"10.1016\/j.jceh.2018.07.005_bib6","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.4161\/cc.5.19.3340","article-title":"Epigenetic activation of tumor suppressor microRNAs in human cancer cells","volume":"5","author":"Saito","year":"2006","journal-title":"J\u00a0Cell Cycle"},{"issue":"1","key":"10.1016\/j.jceh.2018.07.005_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/2045-3701-1-31","article-title":"Regulation of microRNA expression and function by nuclear receptor signaling","volume":"1","author":"Yang","year":"2011","journal-title":"J\u00a0Cell Biosci"},{"issue":"1","key":"10.1016\/j.jceh.2018.07.005_bib8","first-page":"1","article-title":"microRNAs as oncogenes and tumor suppressors","volume":"302","author":"Zhang","year":"2007","journal-title":"J\u00a0Dev Biol"},{"issue":"5","key":"10.1016\/j.jceh.2018.07.005_bib9","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/hep.22806","article-title":"MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma","volume":"49","author":"Tsai","year":"2009","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jceh.2018.07.005_bib10","first-page":"840","article-title":"MicroRNAs: new tools for diagnosis, prognosis and therapy in HCC?","volume":"57","author":"Giordano","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2018.07.005_bib11","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1158\/0008-5472.CAN-08-2886","article-title":"MicroRNA-101, downregulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity","volume":"69","author":"Su","year":"2009","journal-title":"J\u00a0Cancer Res"},{"issue":"2","key":"10.1016\/j.jceh.2018.07.005_bib12","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4103\/2229-3485.179431","article-title":"MicroRNA therapeutics: Discovering novel targets and developing specific therapy","volume":"7","author":"Christopher","year":"2016","journal-title":"J\u00a0Perspect Clin Res."},{"issue":"11","key":"10.1016\/j.jceh.2018.07.005_bib13","first-page":"1951","article-title":"MicroRNA-34a as a therapeutic agent against human cancer","volume":"4","author":"Saito","year":"2015","journal-title":"J\u00a0Clin Med"},{"issue":"3","key":"10.1016\/j.jceh.2018.07.005_bib14","article-title":"Management of hepatocellular carcinoma: an update, AASLD practice guidelines","volume":"53","author":"Bruix","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2018.07.005_bib15","series-title":"Chronic Hepatitis B: Update","author":"Lok","year":"2009"},{"issue":"4","key":"10.1016\/j.jceh.2018.07.005_bib16","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1002\/hep.26359","article-title":"Introduction to the revised American Association for the Study of Liver Diseases practice guideline management of adult patients with ascites due to cirrhosis 2012. AASLD practice guidelines","volume":"57","author":"Runyon","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2018.07.005_bib17","unstructured":"WMA declaration of helsinki \u2013 Ethical principles for medical research\u00a0involving human subjects. www.wma.net\/policies-post\/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects\/. Adopted by the 18th WMA General Assembly, Helsinki, Finland, June 1964 and amended by the: 64th WMA General Assembly, Fortaleza, Brazil, October 2013."},{"key":"10.1016\/j.jceh.2018.07.005_bib18","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jhep.2010.08.021","article-title":"Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis","volume":"54","author":"Um","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2018.07.005_bib19","first-page":"513","article-title":"Allelic imbalances and homozygous deletion on 8p23.2 for stepwise progression of hepatocarcinogenesis","volume":"49","author":"Midorikawa","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2018.07.005_bib20","doi-asserted-by":"crossref","first-page":"5988","DOI":"10.1158\/0008-5472.CAN-08-0905","article-title":"Hepatitis B virus-associated multistep hepatocarcinogenesis: a stepwise increase in allelic alterations","volume":"68","author":"Lee","year":"2008","journal-title":"J\u00a0Cancer Res"},{"key":"10.1016\/j.jceh.2018.07.005_bib21","first-page":"416","article-title":"Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning","volume":"9","author":"Ye","year":"2003","journal-title":"J\u00a0Nat Med"},{"issue":"8","key":"10.1016\/j.jceh.2018.07.005_bib22","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1172\/JCI63966","article-title":"miR-122 regulates hepatic lipid metabolism and tumor suppression","volume":"122","author":"Wen","year":"2012","journal-title":"J\u00a0Clin Invest"},{"issue":"8","key":"10.1016\/j.jceh.2018.07.005_bib23","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/sj.bjc.6605895","article-title":"MicroRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity","volume":"103","author":"Zhang","year":"2010","journal-title":"Brit J Cancer"},{"issue":"2","key":"10.1016\/j.jceh.2018.07.005_bib24","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1158\/1078-0432.CCR-07-0523","article-title":"Association of microRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival","volume":"14","author":"Jiang","year":"2008","journal-title":"J\u00a0Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.jceh.2018.07.005_bib25","first-page":"1098","article-title":"Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma","volume":"49","author":"Ura","year":"2009","journal-title":"J\u00a0Hepatol"},{"issue":"17","key":"10.1016\/j.jceh.2018.07.005_bib26","first-page":"2537","article-title":"Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues","volume":"25","author":"Murakami","year":"2006","journal-title":"J\u00a0Oncogen"},{"key":"10.1016\/j.jceh.2018.07.005_bib27","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mc.20712","article-title":"Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis","volume":"50","author":"Xu","year":"2011","journal-title":"J\u00a0Mol Carcinog"},{"issue":"10","key":"10.1016\/j.jceh.2018.07.005_bib28","article-title":"Serum MicroRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma","volume":"6","author":"Bihrer","year":"2011","journal-title":"J\u00a0PLoS One"},{"issue":"12","key":"10.1016\/j.jceh.2018.07.005_bib29","article-title":"Serum MicroRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection","volume":"6","author":"Qi","year":"2011","journal-title":"J\u00a0PLoS One"},{"key":"10.1016\/j.jceh.2018.07.005_bib30","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jceh.2018.07.005_bib31","first-page":"493","article-title":"STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer","volume":"39","author":"Iliopoulos","year":"2010","journal-title":"J\u00a0Mol Cell"},{"issue":"2","key":"10.1016\/j.jceh.2018.07.005_bib32","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.gastro.2007.05.022","article-title":"MicroRNA- 21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer","volume":"133","author":"Meng","year":"2007","journal-title":"J\u00a0Gastroenterology"},{"issue":"4","key":"10.1016\/j.jceh.2018.07.005_bib33","first-page":"1019","article-title":"microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN","volume":"27","author":"Zhang","year":"2012","journal-title":"J\u00a0Oncol Rep"},{"key":"10.1016\/j.jceh.2018.07.005_bib34","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0960-9822(02)00809-6","article-title":"Identification of tissue-specific microRNAs from mouse","volume":"12","author":"Lagos-Quintana","year":"2002","journal-title":"Curr Biol"},{"key":"10.1016\/j.jceh.2018.07.005_bib35","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1073\/pnas.0813371106","article-title":"Circulating microRNAs, potential biomarkers for drug-induced liver injury","volume":"106","author":"Wang","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9\u201310","key":"10.1016\/j.jceh.2018.07.005_bib36","first-page":"1009","article-title":"Analysis of microRNA expression profiles in human hepatitis B virus-related hepatocellular carcinoma","volume":"59","author":"Li","year":"2013","journal-title":"Clin Lab"},{"key":"10.1016\/j.jceh.2018.07.005_bib37","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1074\/jbc.M707224200","article-title":"Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells","volume":"283","author":"Frankel","year":"2008","journal-title":"J\u00a0Biol Chem"},{"issue":"4","key":"10.1016\/j.jceh.2018.07.005_bib38","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.clinre.2017.06.004","article-title":"Circulating microRNAs panel as a diagnostic tool for discrimination of HCV-associated hepatocellular carcinoma","volume":"41","author":"Ali","year":"2017","journal-title":"J\u00a0Clin Res Hepatol Gastroenterol"},{"issue":"39","key":"10.1016\/j.jceh.2018.07.005_bib39","doi-asserted-by":"crossref","first-page":"66402","DOI":"10.18632\/oncotarget.18949","article-title":"Circulating miRNAs as novel diagnostic biomarkers in hepatocellular carcinoma detection: a meta-analysis based on 24 articles","volume":"8","author":"Ding","year":"2017","journal-title":"J\u00a0Oncotarget"},{"issue":"2","key":"10.1016\/j.jceh.2018.07.005_bib40","first-page":"108","article-title":"Decreased levels of miR-34a and miR-217 act as predictor biomarkers of aggressive progression and poor prognosis in hepatocellular carcinoma","volume":"108","author":"Tian","year":"2017","journal-title":"J\u00a0Minerva Med"},{"issue":"4","key":"10.1016\/j.jceh.2018.07.005_bib41","first-page":"742","article-title":"Expression of microRNA-122 and microRNA-22 in HBV-related liver cancer and the correlation with clinical features","volume":"21","author":"Qiao","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci J"},{"issue":"15","key":"10.1016\/j.jceh.2018.07.005_bib42","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.3748\/wjg.v22.i15.3907","article-title":"MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinoma","volume":"22","author":"Fiorino","year":"2016","journal-title":"World J Gastroenterol"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688318306273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688318306273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:04:55Z","timestamp":1760853895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688318306273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0973688318306273"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2018.07.005","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression Analysis of MicroRNA-21 and MicroRNA-122 in Hepatocellular Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2018.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}